XBIOTECH INC. Research and Development Expense
XBIOTECH INC. (XBIT) reported Research and Development Expense of $5.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- XBIOTECH INC. research and development expense for the quarter ending 2026-06-30 was $5.30M, a 0.75% decline year-over-year.
- XBIOTECH INC. research and development expense for the quarter ending 2026-03-31 was $5.21M, a 55.19% decline year-over-year.
- XBIOTECH INC. research and development expense for the quarter ending 2025-12-31 was $25.36M, a 224.23% increase year-over-year.
- XBIOTECH INC. research and development expense for the quarter ending 2025-09-30 was $5.08M, a 28.72% decline year-over-year.
- XBIOTECH INC. research and development expense for fiscal 2025 was $47.39M, a 25.51% increase from fiscal 2024.
- XBIOTECH INC. research and development expense for fiscal 2024 was $37.76M, a 14.94% increase from fiscal 2023.
- XBIOTECH INC. research and development expense for fiscal 2023 was $32.85M, a 4.13% increase from fiscal 2022.
- XBIOTECH INC. research and development expense for fiscal 2022 was $31.54M, a 11.59% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.30M 10-Q · filed 2026-08-13 | $10.50M 10-Q · filed 2026-08-13 | $35.86M derived: sum of 3 quarters · filed 2026-08-13 | $40.94M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $5.21M 10-Q · filed 2026-05-14 | $30.56M derived: sum of 2 quarters · filed 2026-05-14 | $35.64M derived: sum of 3 quarters · filed 2026-05-14 | $40.98M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $25.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $30.44M derived: sum of 2 quarters · filed 2026-03-13 | $35.77M derived: sum of 3 quarters · filed 2026-08-13 | $47.39M 10-K · filed 2026-03-13 |
| 2025-09-30 | $5.08M 10-Q · filed 2025-11-12 | $10.42M derived: sum of 2 quarters · filed 2026-08-13 | $22.03M 10-Q · filed 2025-11-12 | $29.86M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $5.34M 10-Q · filed 2026-08-13 | $16.95M 10-Q · filed 2026-08-13 | $24.78M derived: sum of 3 quarters · filed 2026-08-13 | $31.90M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $11.62M 10-Q · filed 2026-05-14 | $19.44M derived: sum of 2 quarters · filed 2026-05-14 | $26.57M derived: sum of 3 quarters · filed 2026-05-14 | $39.55M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $7.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $14.95M derived: sum of 2 quarters · filed 2026-03-13 | $27.93M derived: sum of 3 quarters · filed 2026-03-13 | $37.76M 10-K · filed 2026-03-13 |
| 2024-09-30 | $7.13M 10-Q · filed 2025-11-12 | $20.11M derived: sum of 2 quarters · filed 2025-11-12 | $29.94M 10-Q · filed 2025-11-12 | $37.74M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $12.98M 10-Q · filed 2025-08-13 | $22.81M 10-Q · filed 2025-08-13 | $30.61M derived: sum of 3 quarters · filed 2025-08-13 | $38.16M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $9.82M 10-Q · filed 2025-05-14 | $17.63M derived: sum of 2 quarters · filed 2025-05-14 | $25.18M derived: sum of 3 quarters · filed 2025-05-14 | $36.44M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $15.35M derived: sum of 2 quarters · filed 2025-03-18 | $26.62M derived: sum of 3 quarters · filed 2025-03-18 | $32.85M 10-K · filed 2025-03-18 |
| 2023-09-30 | $7.55M 10-Q · filed 2024-11-13 | $18.81M derived: sum of 2 quarters · filed 2024-11-13 | $25.04M 10-Q · filed 2024-11-13 | $32.36M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $11.27M 10-Q · filed 2024-08-12 | $17.50M 10-Q · filed 2024-08-12 | $24.81M derived: sum of 3 quarters · filed 2024-08-12 | $31.83M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $6.23M 10-Q · filed 2024-05-10 | $13.55M derived: sum of 2 quarters · filed 2024-05-10 | $20.56M derived: sum of 3 quarters · filed 2024-05-10 | $30.95M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $14.33M derived: sum of 2 quarters · filed 2024-03-15 | $24.73M derived: sum of 3 quarters · filed 2024-03-15 | $31.54M 10-K · filed 2024-03-15 |
| 2022-09-30 | $7.01M 10-Q · filed 2023-11-09 | $17.41M derived: sum of 2 quarters · filed 2023-11-09 | $24.23M 10-Q · filed 2023-11-09 | $33.01M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $10.39M 10-Q · filed 2023-08-11 | $17.21M 10-Q · filed 2023-08-11 | $25.99M derived: sum of 3 quarters · filed 2023-08-11 | $31.59M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $6.82M 10-Q · filed 2023-05-10 | $15.60M derived: sum of 2 quarters · filed 2023-05-10 | $21.20M derived: sum of 3 quarters · filed 2023-05-10 | $30.45M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $14.38M derived: sum of 2 quarters · filed 2023-03-15 | $23.64M derived: sum of 3 quarters · filed 2023-03-15 | $28.27M 10-K · filed 2023-03-15 |
| 2021-09-30 | $5.60M 10-Q · filed 2022-11-09 | $14.85M derived: sum of 2 quarters · filed 2022-11-09 | $19.49M 10-Q · filed 2022-11-09 | $22.95M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $9.25M 10-Q · filed 2022-08-10 | $13.89M 10-Q · filed 2022-08-10 | $17.35M derived: sum of 3 quarters · filed 2022-08-10 | $19.70M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $4.63M 10-Q · filed 2022-05-10 | $8.10M derived: sum of 2 quarters · filed 2022-05-10 | $10.44M derived: sum of 3 quarters · filed 2022-05-10 | $13.01M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $5.81M derived: sum of 2 quarters · filed 2022-03-15 | $8.37M derived: sum of 3 quarters · filed 2022-03-15 | $9.53M 10-K · filed 2022-03-15 |
| 2020-09-30 | $2.35M 10-Q · filed 2021-11-09 | $4.91M derived: sum of 2 quarters · filed 2021-11-09 | $6.07M 10-Q · filed 2021-11-09 | $16.40M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $2.56M 10-Q · filed 2021-08-09 | $3.72M 10-Q · filed 2021-08-09 | $14.06M derived: sum of 3 quarters · filed 2022-03-15 | $18.59M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $1.16M 10-Q · filed 2021-05-10 | $11.49M derived: sum of 2 quarters · filed 2022-03-15 | $16.02M derived: sum of 3 quarters · filed 2022-03-15 | $20.72M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $14.87M derived: sum of 2 quarters · filed 2022-03-15 | $19.56M derived: sum of 3 quarters · filed 2022-03-15 | $24.09M 10-K · filed 2022-03-15 |
| 2019-09-30 | $4.53M 10-Q · filed 2020-11-09 | $9.23M derived: sum of 2 quarters · filed 2020-11-09 | $13.75M 10-Q · filed 2020-11-09 | $18.60M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $4.69M 10-Q · filed 2020-08-10 | $9.22M 10-Q · filed 2020-08-10 | $14.06M derived: sum of 3 quarters · filed 2021-03-16 | $18.00M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $4.53M 10-Q · filed 2020-05-11 | $9.37M derived: sum of 2 quarters · filed 2021-03-16 | $13.31M derived: sum of 3 quarters · filed 2021-03-16 | $17.26M derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $8.78M derived: sum of 2 quarters · filed 2021-03-16 | $12.73M derived: sum of 3 quarters · filed 2021-03-16 | $15.72M 10-K · filed 2021-03-16 |
| 2018-09-30 | $3.94M 10-Q · filed 2019-11-12 | $7.89M derived: sum of 2 quarters · filed 2019-11-12 | $10.88M 10-Q · filed 2019-11-12 | $16.79M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $3.95M 10-Q · filed 2019-08-09 | $6.94M 10-Q · filed 2019-08-09 | $12.85M derived: sum of 3 quarters · filed 2020-03-16 | $17.78M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $2.99M 10-Q · filed 2019-05-09 | $8.90M derived: sum of 2 quarters · filed 2020-03-16 | $13.83M derived: sum of 3 quarters · filed 2020-03-16 | $21.23M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $10.84M derived: sum of 2 quarters · filed 2020-03-16 | $18.23M derived: sum of 3 quarters · filed 2020-03-16 | $26.42M 10-K · filed 2020-03-16 |
| 2017-09-30 | $4.93M 10-Q · filed 2018-10-31 | $12.33M derived: sum of 2 quarters · filed 2018-10-31 | $20.52M 10-Q · filed 2018-10-31 | $34.20M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $7.40M 10-Q · filed 2018-08-09 | $15.59M 10-Q · filed 2018-08-09 | $29.27M derived: sum of 3 quarters · filed 2019-03-15 | $39.05M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $8.19M 10-Q · filed 2018-05-08 | $21.87M derived: sum of 2 quarters · filed 2019-03-15 | $31.65M derived: sum of 3 quarters · filed 2019-03-15 | $42.86M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $13.69M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | $23.46M derived: sum of 2 quarters · filed 2019-03-15 | $34.67M derived: sum of 3 quarters · filed 2019-03-15 | $42.49M 10-K/A · filed 2019-03-15 |
| 2016-09-30 | $9.77M 10-Q · filed 2017-11-09 | $20.99M derived: sum of 2 quarters · filed 2017-11-09 | $28.80M 10-Q · filed 2017-11-09 | $39.22M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $11.22M 10-Q · filed 2017-08-08 | $19.03M 10-Q · filed 2017-08-08 | $29.44M derived: sum of 3 quarters · filed 2018-03-16 | $39.17M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $7.81M 10-Q · filed 2017-05-10 | $18.23M derived: sum of 2 quarters · filed 2018-03-16 | $27.96M derived: sum of 3 quarters · filed 2018-03-16 | $32.34M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $20.14M derived: sum of 2 quarters · filed 2018-03-16 | $24.53M derived: sum of 3 quarters · filed 2018-03-16 | $31.31M 10-K · filed 2018-03-16 |
| 2015-09-30 | $9.73M 10-Q · filed 2016-11-14 | $14.11M derived: sum of 2 quarters · filed 2016-11-14 | $20.90M 10-Q · filed 2016-11-14 | $25.29M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $4.38M 10-Q · filed 2016-08-12 | $11.17M 10-Q · filed 2016-08-12 | $15.56M derived: sum of 3 quarters · filed 2017-03-16 | $19.90M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $6.78M 10-Q · filed 2016-05-13 | $11.18M derived: sum of 2 quarters · filed 2017-03-16 | $15.52M derived: sum of 3 quarters · filed 2017-03-16 | $18.76M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $8.73M derived: sum of 2 quarters · filed 2017-03-16 | $11.98M derived: sum of 3 quarters · filed 2017-03-16 | $14.33M 10-K · filed 2017-03-16 |
| 2014-09-30 | $4.34M 10-Q · filed 2015-11-13 | $7.59M derived: sum of 2 quarters · filed 2015-11-13 | $9.94M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $3.25M 10-Q · filed 2015-08-14 | $5.60M 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $2.35M 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | $7.93M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |